Get startedLog in
    Picture of Kiniksa Pharmaceuticals International logo

    KNSA — Kiniksa Pharmaceuticals International News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance

    Picture of Kiniksa Pharmaceuticals International logoKiniksa Pharmaceuticals International
    13/01/2025 13:48
    Jan 13 (Reuters) - Kiniksa Pharmaceuticals International
PLC  KNSA.O :
    * KINIKSA PHARMACEUTICALS INTERNATIONAL PLC - ARCALYST 2024
NET
PRODUCT REVENUE $416.4 MILLION, 79% YOY GROWTH
    * KINIKSA PHARMACEUTICALS INTERNATIONAL PLC - ARCALYST Q4
2024 NET
PRODUCT REVENUE $121.9 MILLION
    * KINIKSA PHARMACEUTICALS INTERNATIONAL - ARCALYST 2025 NET
PRODUCT REVENUE EXPECTED $560-$580 MILLION

Source text:  ID:nGNX5lxxJP 
Further company coverage:  KNSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kiniksa Pharmaceuticals International

    See all news